BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38583124)

  • 41. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation.
    Klumpp TR; Herman JH; Ulicny J; Emmons RV; Martin ME; Mangan KF
    Bone Marrow Transplant; 2006 Nov; 38(9):615-20. PubMed ID: 16964267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk Factors for Graft-Versus-Host Disease and Survival in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience.
    Bedir Demirdağ T; Kurşun Ağlamiş G; Kirkiz Kayal S; Uğraş Dikmen A; Kaya Z; Yenicesu İ; Koçak Ü
    Exp Clin Transplant; 2021 Nov; ():. PubMed ID: 34775938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response to comment on: 'Synchronous multiple non-small cell lung cancers in an allograft lung recipient'.
    Pujol JL; Bommart S; Pujol P
    Lung Cancer; 2019 May; 131():155-156. PubMed ID: 30935718
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence of viral infections and hemorrhagic cystitis in hematopoietic stem cell transplant recipients.
    Shakiba E; Yaghobi R; Ramzi M
    Exp Clin Transplant; 2011 Dec; 9(6):405-12. PubMed ID: 22142049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deep Sequencing of Urine Specimens Detects Two BK Polyomavirus Genotypes in a Hematopoietic Stem Cell Transplant Recipient.
    Van TD; Dwyer DE; Jeoffreys N; Kok J; Nankivell BJ; Rockett RJ
    Microbiol Resour Announc; 2020 Jan; 9(5):. PubMed ID: 32001567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Kosmaczewska A; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Ciszak L; Jagoda K; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunol Lett; 2015 May; 165(1):52-9. PubMed ID: 25841352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Theoretical Basis of In Utero Hematopoietic Stem Cell Transplantation and Its Use in the Treatment of Blood Disorders.
    Tai-MacArthur S; Lombardi G; Shangaris P
    Stem Cells Dev; 2021 Jan; 30(2):49-58. PubMed ID: 33280478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.
    Nakamae H; Storer B; Sandmaier BM; Maloney DG; Davis C; Corey L; Storb R; Boeckh M
    Haematologica; 2011 Dec; 96(12):1838-45. PubMed ID: 21880629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Khattab A; Patruni S; Patrus G; Samhouri Y; Fazal S; Lister J
    J Hematol; 2023 Jun; 12(3):138-144. PubMed ID: 37435412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
    Gadalla SM; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Katki HA; Lee SJ; Savage SA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2276-2282. PubMed ID: 27641680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient.
    Fujiwara Y; Matsuoka KI; Iwamoto M; Sumii Y; Abe M; Mizuhara K; Urata T; Saeki K; Meguri Y; Asada N; Ennishi D; Nishimori H; Fujii K; Fujii N; Sugita J; Kobayashi H; Oto T; Maeda Y
    Int J Hematol; 2020 Dec; 112(6):871-877. PubMed ID: 32803699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Donor-derived type II pneumocytes are rare in the lungs of allogeneic hematopoietic cell transplant recipients.
    Zander DS; Cogle CR; Theise ND; Crawford JM
    Ann Clin Lab Sci; 2006; 36(1):47-52. PubMed ID: 16501236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of collaborative practice agreements held by hematopoietic stem cell transplant pharmacists.
    Bryk A; Koontz S; Mayor J; Betcher J; Tombleson R; Bookout R; Saunders IM
    J Oncol Pharm Pract; 2019 Apr; 25(3):558-566. PubMed ID: 29207938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Preliminary Online Study on Menstruation Recovery in Women After Autologous Hematopoietic Stem Cell Transplant for Autoimmune Diseases.
    Maciejewska M; Snarski E; Wiktor-Jędrzejczak W
    Exp Clin Transplant; 2016 Dec; 14(6):665-669. PubMed ID: 27310497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of a Pediatric Early Warning Score in Hospitalized Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
    Agulnik A; Forbes PW; Stenquist N; Rodriguez-Galindo C; Kleinman M
    Pediatr Crit Care Med; 2016 Apr; 17(4):e146-53. PubMed ID: 26914628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe sepsis in hematopoietic stem cell transplant recipients*.
    Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
    Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of bone mineral density changes in pediatric thalassemic patients with and without hematopoietic stem cell transplant.
    Hamidieh AA; Mohajeri-Tehrani MR; Behfar M; Vaghari-Meher N; Alimoghaddam K; Mohseni F; Ghavamzadeh A; Larijani B; Hamidi Z
    Exp Clin Transplant; 2015 Apr; 13(2):173-8. PubMed ID: 25394210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relation between costimulatory molecule polymorphism and hepatitis B infections in hematopoietic stem cell transplant recipients.
    Yaghobi R; Saadi MI; Karimi MH; Geramizadeh B; Ramzi M; Zakerinia M
    Exp Clin Transplant; 2014 Aug; 12(4):357-66. PubMed ID: 24188429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Capanni M; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2008; 40(1):84-90. PubMed ID: 17964828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telomeres, X-inactivation ratios, and hematopoietic stem cell transplantation in humans: a review.
    Thornley I; Freedman MH
    Stem Cells; 2002; 20(3):198-204. PubMed ID: 12004078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.